EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieVergleichsstudieKlinische Studie (Phase III)

A Prospective Randomized Multicenter Study on the Impact of [ 18 F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer

Laura Evangelista, Fabio Zattoni, Marta Burei, Daniele Bertin, Eugenio Borsatti, Tanja Baresic, Mohsen Farsad, Emanuela Trenti, Mirco Bartolomei, Stefano Panareo, Luca Urso, Giuseppe Trifirò und 10 weitere

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.123.267355 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Laura Evangelista und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; laura.evangelista@hunimed.eu. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Choline, Neoplasm Staging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to compare the efficacy of [18F]F-choline PET/CT with conventional imaging for staging and managing intermediate- to high-risk prostate cancer (PCa). The primary objective was to assess the ability of PET/CT with [18F]F-choline to identify lymph node and systemic involvement during initial staging. Secondary objectives included evaluating the impact of [18F]F-choline PET/CT on unnecessary local treatments and assessing the safety of [18F]F-choline agents. Additionally, the study aimed to analyze recurrence-free survival and overall survival 5 y after randomization.

Methods

A prospective controlled, open, randomized multicenter phase III trial involving 7 Italian centers was conducted. Eligible patients with intermediate- to high-risk PCa were randomized in a 1:1 ratio. Two groups were formed: one undergoing conventional imaging (abdominopelvic contrast-enhanced CT and bone scanning) and the other receiving conventional imaging plus [18F]F-choline PET/CT. The study was terminated prematurely; however, all the endpoints were thoroughly analyzed and enriched.

Results

Between February 2016 and December 2020, 256 patients were randomly assigned. In total, 236 patients (117 in the control arm and 119 in the experimental arm) were considered for the final assessment. In the experimental arm, the sensitivity for lymph node metastases, determined by final pathology and serial prostate-specific antigen evaluations, was higher than in the control arm (77.78% vs. 28.57% and 65.62% vs. 17.65%, respectively). The [18F]F-choline was tolerated well. The use of [18F]F-choline PET/CT resulted in an approximately 8% reduction in unnecessary extended lymphadenectomy compared with contrast-enhanced CT. Additionally, [18F]F-choline PET/CT had a marginal impact on 5-y overall survival, contributing to a 4% increase in survival rates.

Conclusion

In the initial staging of PCa, [18F]F-choline PET/CT exhibited diagnostic performance superior to that of conventional imaging for detecting metastases. [18F]F-choline PET/CT reduced the rate of unnecessary extensive lymphadenectomy by up to 8%. These findings support the consideration of discontinuing conventional imaging for staging PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyCholineNeoplasm StagingHumansMaleAgedProspective StudiesMiddle AgedFluorine Radioisotopes

Stichwörter der Autor:innen

diagnostic imagingdisease managementfluorocholineprognosisprostate cancer

Substanzen

CholinefluoromethylcholineFluorine Radioisotopes

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy; laura.evangelista@hunimed.eu.
  • Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Rozzano, Italy.
  • Urology Unit, Department of Surgery, Oncology, and Gastroenterology, Urologic Unit, University of Padua, Padua, Italy.
  • Department of Medicine, DIMED, University of Padua, Padua, Italy.
  • Nuclear Medicine Unit, Veneto Institute of Oncology, Padua, Italy.
  • Nuclear Medicine Unit, Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Italy

Zitieren

APA

Evangelista, L., Zattoni, F., Burei, M., Bertin, D., Borsatti, E., Baresic, T., Farsad, M., Trenti, E., Bartolomei, M., Panareo, S., Urso, L., Trifirò, G., Brugola, E., Chierichetti, F., Donner, D., Setti, L., Gallan, M., Del Bianco, P., Magni, G., …, & Study Group Coinvestigators (2024). A Prospective Randomized Multicenter Study on the Impact of [ 18 F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.123.267355

Vancouver

Evangelista L, Zattoni F, Burei M, Bertin D, Borsatti E, Baresic T, et al. A Prospective Randomized Multicenter Study on the Impact of [ 18 F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.123.267355

BibTeX
@article{Evangelista2024,
  author = {Evangelista, Laura and Zattoni, Fabio and Burei, Marta and Bertin, Daniele and Borsatti, Eugenio and Baresic, Tanja and Farsad, Mohsen and Trenti, Emanuela and Bartolomei, Mirco and Panareo, Stefano and Urso, Luca and Trifirò, Giuseppe and Brugola, Elisabetta and Chierichetti, Franca and Donner, Davide and Setti, Lucia and Gallan, Mauro and Del Bianco, Paola and Magni, Giovanna and De Salvo, Gian Luca and Novara, Giacomo and Study Group Coinvestigators, Study Group Coinvestigators},
  title = {A Prospective Randomized Multicenter Study on the Impact of [ 18 F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.123.267355}
}
Kostenlos starten →